| MC 2746 Ponatinib hydrochloride, [14C]- | |
|
MORpure™
HPLC purified, Delivered ≥ 97% pure with dated HPLC radiochromatogram
|
|
| Ethanol solution, 1.0 mCi/ml | |
| > 5 Ci(185 GBq)/mmol | Please Inquire for Pricing |
| NextGen V-Vial - shipped on dry ice | |
| M.W. 236.27 | |
| This material is pharmaceutically unrefined, and not intended for use in humans, clinical diagnosis, or data derived from its use to support regulatory filings. | |
| MC 2747 Ponatinib hydrochloride LSA, [14C]- | |
|
MORpure™
HPLC purified, Delivered ≥ 98% pure with dated HPLC radiochromatogram
|
|
| Solid | |
| ≥ 50 mCi (1.85 GBq)/mmol | Please Inquire for Pricing |
| NextGen V-Vial - shipped on dry ice | |
M.W.
236.27
 | |
| This material is pharmaceutically unrefined, and not intended for use in humans, clinical diagnosis, or data derived from its use to support regulatory filings. | |
| MC 2748 Ponatinib, [14C]- | |
|
MORpure™
HPLC purified, Delivered ≥ 98% pure with dated HPLC radiochromatogram
|
|
| Solid | |
| ≥ 50 mCi (1.85 GBq)/mmol | Please Inquire for Pricing |
| NextGen V-Vial - shipped on dry ice | |
| M.W.
236.27
| |
| This material is pharmaceutically unrefined, and not intended for use in humans, clinical diagnosis, or data derived from its use to support regulatory filings. | |